Free Trial

Aerovate Therapeutics (AVTE) SEC Filings & 10K Form

Aerovate Therapeutics logo
$7.49 -0.23 (-2.92%)
As of 05/21/2025

Recent Aerovate Therapeutics SEC Filings

DateFilerForm TypeView
05/05/2025
8:43 AM
Frazier Life Sciences Public Fund, L.P. (Filed by)
Aerovate Therapeutics (Subject)
Form SCHEDULE 13G
05/01/2025
5:31 PM
Fairmount Funds Management LLC (Filed by)
Aerovate Therapeutics (Subject)
Form SCHEDULE 13D
05/01/2025
4:44 PM
Aerovate Therapeutics (Issuer)
Klein Lawrence Otto (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
05/01/2025
4:51 PM
Aerovate Therapeutics (Issuer)
Lavelle Erin (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
05/01/2025
4:58 PM
Fairmount Funds Management LLC (Reporting)
Fairmount Healthcare Fund II L.P. (Reporting)
Harwin Peter Evan (Reporting)
Aerovate Therapeutics (Issuer)
Kiselak Tomas (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
05/01/2025
5:00 PM
DOBMEIER ERIC (Reporting)
Aerovate Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/01/2025
5:07 PM
CAIN CHRISTOPHER W. (Reporting)
Aerovate Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/01/2025
5:10 PM
Aerovate Therapeutics (Issuer)
Klein Lawrence Otto (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/01/2025
5:15 PM
Aerovate Therapeutics (Issuer)
Lavelle Erin (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/01/2025
5:16 PM
Fairmount Funds Management LLC (Reporting)
Fairmount Healthcare Fund II L.P. (Reporting)
Harwin Peter Evan (Reporting)
Aerovate Therapeutics (Issuer)
Kiselak Tomas (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/01/2025
4:21 PM
Frohlich Tom (Reporting)
Aerovate Therapeutics (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
05/01/2025
4:22 PM
Aerovate Therapeutics (Issuer)
Quick Jonathan (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
05/01/2025
4:27 PM
Aerovate Therapeutics (Issuer)
King Andrew James (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
05/01/2025
4:30 PM
Aerovate Therapeutics (Issuer)
Kocinsky Hetal (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
05/01/2025
4:32 PM
Balta Elizabeth (Reporting)
Aerovate Therapeutics (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
05/01/2025
4:39 PM
DOBMEIER ERIC (Reporting)
Aerovate Therapeutics (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
05/01/2025
4:41 PM
CAIN CHRISTOPHER W. (Reporting)
Aerovate Therapeutics (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
05/01/2025
3:22 PM
Aerovate Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/25/2025
3:30 PM
Aerovate Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
04/23/2025
3:37 PM
Aerovate Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/21/2025
7:07 AM
Aerovate Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/09/2025
3:20 PM
Aerovate Therapeutics (Subject)
Form 425
04/09/2025
6:00 AM
Aerovate Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/09/2025
6:01 AM
Aerovate Therapeutics (Subject)
Form 425
04/07/2025
7:39 AM
Aerovate Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/07/2025
7:42 AM
Aerovate Therapeutics (Subject)
Form 425
04/07/2025
7:46 AM
Aerovate Therapeutics (Subject)
Form 425
03/27/2025
6:30 AM
Aerovate Therapeutics (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
03/26/2025
3:54 PM
Aerovate Therapeutics (Subject)
Form 425
03/25/2025
11:15 PM
Aerovate Therapeutics (Filer)
Form EFFECT
03/25/2025
3:25 PM
Aerovate Therapeutics (Filer)
Form 424B3
03/24/2025
9:45 AM
Aerovate Therapeutics (Filer)
Form S-4/A
03/14/2025
4:16 PM
Aerovate Therapeutics (Filer)
Form S-4/A
03/03/2025
3:45 PM
Aerovate Therapeutics (Subject)
Form 425
02/24/2025
8:57 AM
Aerovate Therapeutics (Filer)
Form S-4/A
01/24/2025
3:17 PM
Aerovate Therapeutics (Subject)
Form 425
01/22/2025
7:45 AM
Aerovate Therapeutics (Filer)
Form S-4/A
01/13/2025
4:24 PM
Aerovate Therapeutics (Subject)
Form 425
12/03/2024
5:27 AM
Aerovate Therapeutics (Filer)
Form S-4
Registration statement under Securities Act of 1933  
11/18/2024
4:29 PM
Aerovate Therapeutics (Subject)
Form 425
10/31/2024
3:55 PM
Aerovate Therapeutics (Subject)
Form 425
Buffett’s favorite chart just hit 209% – here’s what that means for gold (Ad)

A Historic Gold Announcement Is About to Rock Wall Street For months, sharp-eyed analysts have watched the quiet buildup behind the scenes. Now, in just days, the floodgates are set to open. The greatest investor of all time is about to validate what Garrett Goggin has been saying for months: Gold is entering a once-in-a-generation mania. Front-running Buffett has never been more urgent — and four tiny miners could be your ticket to 100X gains.

Be ready before the historic gold move. Get Garrett’s Top Four picks now.
10/31/2024
3:55 PM
Aerovate Therapeutics (Subject)
Form 425
10/31/2024
3:57 PM
Aerovate Therapeutics (Subject)
Form 425
10/31/2024
3:57 PM
Aerovate Therapeutics (Subject)
Form 425
10/31/2024
8:27 AM
Aerovate Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/31/2024
8:29 AM
Aerovate Therapeutics (Subject)
Form 425
10/17/2024
3:59 PM
Aerovate Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/10/2024
4:04 PM
Aerovate Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/12/2024
3:31 PM
Aerovate Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
08/02/2024
5:00 PM
Aerovate Therapeutics (Issuer)
Dake Benjamin T (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/08/2024
7:00 AM
Aerovate Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/20/2024
5:00 PM
Aerovate Therapeutics (Subject)
RA CAPITAL MANAGEMENT, L.P. (Filed by)
Form SC 13D/A
06/20/2024
4:56 PM
Aerovate Therapeutics (Issuer)
Kolchinsky Peter (Reporting)
RA Capital Healthcare Fund LP (Reporting)
RA CAPITAL MANAGEMENT, L.P. (Reporting)
RA Capital Nexus Fund, L.P. (Reporting)
Shah Rajeev M. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/17/2024
7:35 AM
Aerovate Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/14/2024
5:00 PM
Aerovate Therapeutics (Issuer)
Gillies Hunter (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/14/2024
5:00 PM
Aerovate Therapeutics (Issuer)
Verwijs Marinus (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/14/2024
5:00 PM
Aerovate Therapeutics (Issuer)
Eldridge George A (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/13/2024
3:44 PM
Aerovate Therapeutics (Subject)
Gillies Hunter (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
06/10/2024
4:00 PM
Aerovate Therapeutics (Filer)
Form S-3
Registration statement under Securities Act of 1933  
06/07/2024
7:29 PM
Aerovate Therapeutics (Issuer)
Kolchinsky Peter (Reporting)
RA Capital Healthcare Fund LP (Reporting)
RA CAPITAL MANAGEMENT, L.P. (Reporting)
RA Capital Nexus Fund, L.P. (Reporting)
Shah Rajeev M. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/07/2024
5:00 PM
Aerovate Therapeutics (Issuer)
Dorval Allison (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/07/2024
5:00 PM
Aerovate Therapeutics (Issuer)
Dable Habib J (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/07/2024
5:00 PM
Aerovate Therapeutics (Issuer)
GRAYZEL DAVID S. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/07/2024
5:00 PM
Aerovate Therapeutics (Issuer)
Iwicki Mark T (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/07/2024
5:00 PM
Aerovate Therapeutics (Issuer)
Katabi Maha (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/07/2024
5:00 PM
Aerovate Therapeutics (Issuer)
Resnick Joshua (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/07/2024
5:00 PM
Aerovate Therapeutics (Issuer)
Santel Donald J (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
(Data available from 1/1/2016 forward)


Related Companies and Tools


This page (NASDAQ:AVTE) was last updated on 5/23/2025 by MarketBeat.com Staff
From Our Partners